Organovo Holdings:Study Showed Statistically Significant Reduction in Liver Fat Content From Baseline in Patients Receiving Fxr314 Compared to Placebo
Organovo Holdings: 研究显示,与安慰剂相比,接受Fxr314治疗的患者的肝脂含量比基线显著降低
Organovo Holdings:Study Showed Statistically Significant Reduction in Liver Fat Content From Baseline in Patients Receiving Fxr314 Compared to Placebo
Organovo Holdings: 研究显示,与安慰剂相比,接受Fxr314治疗的患者的肝脂含量比基线显著降低
使用浏览器的分享功能,分享给你的好友吧